LONDON (AP) — The European Medicines Agency said Tuesday that AstraZeneca and Oxford University have submitted an application for their COVID-19 vaccine to be licensed across the European...
MADRID (AP) — The Spanish capital of Madrid was still trying to get back on its feet Monday after a 50-year record snowfall that paralyzed large parts of central Spain and was hampering the...
The Miami-Dade County Medical Examiner is investigating the death of a doctor weeks after he received a Covid-19 vaccine, according to Darren Caprara, director of operations at the medical examiner's office.
Driven by the growing research and development efforts by global players, therapeutic agent for novel coronavirus (COVID-19) could soon be approved
The Moderna vaccine is 94.5% effective against coronavirus, according to early data released Monday by the company, making it the second vaccine in the United States to have a stunningly high success rate.
Two major clinical trials for coronavirus vaccines are resuming in the United States, after being paused over safety concerns.
Top U.S. infectious diseases expert Anthony Fauci said on Thursday it is unlikely a COVID-19 vaccine will be ready by the end of October, but that it is not impossible.
"That process would generally be measured in years ... So it was a sprint, to say the least."
Anthony Fauci, the nation’s top infectious diseases expert, said Tuesday he doesn’t see the U.S. mandating a COVID-19 vaccine.
U.S. government scientists have begun efforts to manufacture a strain of the novel coronavirus that could be used in human challenge trials of vaccines, a controversial type of study in which healthy volunteers would be vaccinated and then intentionally infected with the virus, Reuters has learned.
‘You must never abandon the public-health approach,’ Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told a live...
An epidemiologist and infectious disease specialist answer questions about a COVID-19 vaccine, including what happens after a vaccine is approved and availab...
Who will be first in line for a COVID-19 vaccine? U.S. health authorities hope by late next month to have some draft guidance on how to ration initial doses, but it's a vexing decision.
Madonna has been censored on Instagram for spreading false information about a supposed COVID-19 cure. The pop diva claimed that a proven vaccine had been available for months but it was being kept secret.
Two Chinese cybercriminals have been indicted by the US Justice Department for trying to steal COVID-19 vaccine research and hacking hundreds of companies in the US and abroad, including defence contractors.
And the Bahamas announces a ban on American travelers due to the virus surge in the U.S. ABC’s Mona Kosar Abdi reports. BREAKING NEWS UPDATES: https://abcnew...
US, UK and Canada alleged Russian hacking group APT29, also known as Cozy Bear, to be attacking academic and pharmaceutical research institutions working on COVID-19 vaccines.
Trial vaccine elicits ‘robust’ immune-system response in larger group of people, Moderna said.
Early-stage testing showed the first COVID-19 vaccine tested in the U.S. revved up people's immune systems the way scientists had hoped.
Early-stage testing showed the first COVID-19 vaccine tested in the U.S. revved up people's immune systems the way scientists had hoped.
Stocks moved higher to start the third quarter.
Amid a global race to find COVID-19 vaccine, a team of Nigerian scientists recently announced the discovery of a novel coronavirus vaccine that may help prevent the SARS-CoV-2 virus infection, according to a report by The Guardian Nigeria.
Sen. Rick Scott (R-Fla.) accused China of trying to sabotage the development of a coronavirus vaccine on Sunday without providing details to back up his claims.
Trump will make an announcement regarding U.S.-China relations on Friday.
Even after a COVID-19 vaccine is developed and deployed, the coronavirus will likely remain for years to come, and may eventually, become endemic like HIV, measles and chickenpox, says a report.
CNBC.com’s MacKenzie Sigalos brings you the day’s top business news headlines, and what to watch as the coronavirus pandemic continues to keep most of America on lockdown. On today’s show, CNBC’s Michael Sheetz explains what’s at stake in tomorrow’s historic SpaceX launch of two NASA astronauts. Plus, the latest on the development of a coronavirus vaccine as heavyweight Merck jumps into the race.
Only about half of Americans say they would get a COVID-19 vaccine if the scientists working furiously to create one succeed, a number that's surprisingly low considering the effort going into the global race for a vaccine.
Ethicists and physicians are concerned that, amid a desire to put an end to the Covid-19 pandemic, developers of drugs and vaccines have become overly enthusiastic about the chances their products will work.
Moderna's stock price skyrocketed as much as 30% on Monday after the biotech company announced promising early results for its coronavirus vaccine. As ordinary investors piled in, two insiders were quietly heading for the exits.
Pharmaceutical company AstraZeneca says it has secured orders for at least 400 million doses of an unproven Covid-19 vaccine that it will be able to start delivering this year. It announced on Thursday that it had “concluded the first agreements” to make the University of Oxford’s potential coronavirus vaccine.
A quarter of Americans have little or no interest in taking a coronavirus vaccine, a Reuters/Ipsos poll published on Thursday found, with some voicing concern that the record pace at which vaccine candidates are being developed could compromise safety.
A novel coronavirus vaccine trial in the US has now given a dose to its first participant, the National Institute of Allergy and Infectious Diseases announced Monday.
